Literature DB >> 1981322

Lithium and the natriuretic response to gludopa, fenoldopam and dopamine.

D F Schoors, A G Dupont.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981322      PMCID: PMC1368262          DOI: 10.1111/j.1365-2125.1990.tb03830.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  7 in total

1.  Lithium does not reduce the natriuretic response to dopamine in man.

Authors:  D F Schoors; A G Dupont
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

2.  The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man.

Authors:  R F Jeffrey; T M Macdonald; J Brown; P W Rae; M R Lee
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

3.  Evidence that specific dopamine-1 receptor activation is involved in dopamine-induced renin release.

Authors:  I Antonipillai; M I Broers; D Lang
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190

4.  Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats.

Authors:  I Cavero; C Thiry; J Pratz; K Lawson
Journal:  Clin Exp Hypertens A       Date:  1987

5.  The effect of fenoldopam, a dopaminergic agonist, on renal hemodynamics.

Authors:  N L Allison; J W Dubb; J A Ziemniak; F Alexander; R M Stote
Journal:  Clin Pharmacol Ther       Date:  1987-03       Impact factor: 6.875

6.  The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man.

Authors:  J M Hughes; T R Beck; C E Rose; R M Carey
Journal:  J Clin Endocrinol Metab       Date:  1988-03       Impact factor: 5.958

7.  Lack of effect of lithium on the renal response to DA1-dopamine receptor stimulation by fenoldopam in normal man.

Authors:  A R Girbes; A J Smit; S Meijer; W D Reitsma
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.